Volume 13, Issue 3 pp. 263-271

Clarifying the term ‘palliative’ in clinical oncology

T. VAN KLEFFENS msc

Corresponding Author

T. VAN KLEFFENS msc

Department of Philosophy and Medical Ethics,

Titia van Kleffens, VU University Medical Center, Philosophy and Medical Ethics, Van der Boechorststraat 7, 1081 BT Amsterdam, the Netherlands (e-mail: [email protected]).Search for more papers by this author
B. VAN BAARSEN phd

B. VAN BAARSEN phd

Department of Philosophy and Medical Ethics,

Search for more papers by this author
K. HOEKMAN md phd

K. HOEKMAN md phd

Department of Medical Oncology &

Search for more papers by this author
E. VAN LEEUWEN phd

E. VAN LEEUWEN phd

Department of Philosophy and Medical Ethics, VU University Medical Center, Amsterdam, the Netherlands

Search for more papers by this author
First published: 14 June 2004
Citations: 31

Abstract

The objective of this study was to clarify the term ‘palliative’ in clinical oncology. A qualitative study design with in-depth interviews was applied. The study sample included 30 cancer patients and 16 physicians.

In clinical oncology, the use of the term ‘palliative’ to describe both anticancer treatments and palliative care may cause confusion and misunderstanding. Different aspects of palliative care, as expressed by the WHO definition, are not so easily recognizable with regard to palliative oncological treatments. Furthermore, the fact that the same anticancer treatments can be given to patients with palliative or curative intention is confusing. The distinction between curative and palliative oncological treatments is of crucial importance for the treatment decision-making process. Close consideration of the use of the term ‘palliative’ will help to clarify the various goals of treatment and care in oncological practice.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.